Lucille Stuani is currently a Researcher in the Junior Professor Chair at Montpellier Cancer Research Institute since January 2023. Previously, Lucille worked as a Post-doc fellow at Stanford University School of Medicine from February 2021 to December 2022, focusing on intratumoral metabolic heterogeneity in acute myeloid leukemia (AML) cells. Prior experience includes a post-doctoral position at the Cancer Research Center of Toulouse from February 2015 to February 2021, where the investigation centered on chemoresistance in AML cells through integrative omics. Earlier roles featured a PhD focused on the identification of metabolic functions in Acinetobacter baylyi ADP1 at Genoscope from April 2011 to October 2014, alongside internships in analytical chemistry at Clariant and the Marine Institute. Lucille's academic credentials include a PhD in Analytical Chemistry from Université Évry Paris-Saclay and a Master's in Analytical Sciences from Strasbourg University.
This person is not in the org chart
IRCM - Institut de Recherche en Cancérologie de Montpellier
The Cancer Research Institute of Montpellier U1194 jointly operated by Inserm, University of Montpellier and Institut du Cancer de Montpellier (CLCC) 220 scientists and support personnel 17 research teams sharing 5000 m2 of lab space Excellent core facilities, many being part of the shared facilities network Montpellier BioCampus Biotech spin-offs Ground breaking research in basic and translational oncology developed in close collaboration with clinical departments and clinical research at ICM One central theme and two unifying programs : Molecular Targets and Cancer Therapy 1. Plasticity of solid tumors : from discoveries to personalized medecine 2. Therapeutic Antibodies in Cancer Treatment : Innovation, design and biological response